Par-2-activating peptide derivative and pharmaceutical composition using the same
CA 2488937 A1 · Owner: Wang, Pu · Inventors: Kanke, Toru; Jiang, Lu; Plevin, Robin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a peptide derivative represented by the general formula (I) or a salt thereof: Z-(CH2)n-CO-NH-Leu-Ile-Gly-AA1-AA2-CO-R (I) wherein Z represents an aryl group which may or may not have a substituent or a heteroaryl group which may or may not have a substituent; n represents 0 1 or 2; AA1-AA2 represents Lys-Val or Arg-Leu; and R represents -OH or -NH2 and relates to a pharmaceutical composition comprising a peptide derivative represented by the general formula (I) or a salt thereof and a , pharmaceutically acceptable carrier thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 10, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 10, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 10, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.